Metabolites
Displaying compounds 1326 - 1350 of 16042 in total
| YMDB ID | Name CAS Number | IUPAC Name | Formula Weight | Structure |
|---|---|---|---|---|
| YMDB13273 | LPA(14:0/0:0) | [2-hydroxy-3-(tetradecanoyloxy)propoxy]phosphonic acid | C17H35O7P 382.434 |  |
| YMDB01489 | 7,8-Didehydrodesmosterol 1715-86-2 | (1S,2R,5S,11R,14R,15R)-2,15-dimethyl-14-[(2R)-6-methylhept-5-en-2-yl]tetracyclo[8.7.0.0^{2,7}.0^{11,15}]heptadeca-7,9-dien-5-ol | C27H42O 382.6218 |  |
| YMDB00608 | zymosterol intermediate 2 128-33-6 | (2S,7S,11R,14R,15R)-2,15-dimethyl-14-[(2R)-6-methylhept-5-en-2-yl]tetracyclo[8.7.0.0²,⁷.0¹¹,¹⁵]heptadec-1(10)-en-5-one | C27H42O 382.6218 |  |
| YMDB00198 | S-Adenosylhomocysteine 979-92-0 | (2S)-2-amino-4-({[(2S,3S,4R,5R)-5-(6-amino-9H-purin-9-yl)-3,4-dihydroxyoxolan-2-yl]methyl}sulfanyl)butanoic acid | C14H20N6O5S 384.411 |  |
| YMDB13388 | MG(20:1(11Z/0:0)/0:0/0:0) | (2R)-2,3-dihydroxypropyl (11Z)-icos-11-enoate | C23H44O4 384.601 |  |
| YMDB13389 | MG(20:1(9Z/0:0)/0:0/0:0) | (2R)-2,3-dihydroxypropyl (9Z)-icos-9-enoate | C23H44O4 384.601 |  |
| YMDB00548 | zymosterol 7488-99-5 | (2S,5S,7S,11R,14R,15R)-2,15-dimethyl-14-[(2R)-6-methylhept-5-en-2-yl]tetracyclo[8.7.0.0^{2,7}.0^{11,15}]heptadec-1(10)-en-5-ol | C27H44O 384.6377 |  |
| YMDB16151 | Desmosterol | (1S,2R,5S,10S,11S,14R,15R)-2,15-dimethyl-14-[(2R)-6-methylhept-5-en-2-yl]tetracyclo[8.7.0.0^{2,7}.0^{11,15}]heptadec-7-en-5-ol | C27H44O 384.6377 |  |
| YMDB01533 | L-Palmitoylcarnitine | (4S)-4-[(3-hydroxytetradec-5-enoyl)oxy]-4-(trimethylazaniumyl)butanoate | C21H39NO5 385.5381 |  |
| YMDB13387 | MG(20:0/0:0/0:0) | (2R)-2,3-dihydroxypropyl icosanoate | C23H46O4 386.617 |  |
| YMDB00313 | Cholesterol 57-88-5 | (1S,2R,10S,11S,14R,15R)-2,15-dimethyl-14-[(2R)-6-methylheptan-2-yl]tetracyclo[8.7.0.0²,⁷.0¹¹,¹⁵]heptadec-7-en-5-ol | C27H46O 386.6535 |  |
| YMDB00916 | dCDP 800-73-7 | [({[(2R,3S,5R)-5-(4-amino-2-oxo-1,2-dihydropyrimidin-1-yl)-3-hydroxyoxolan-2-yl]methoxy}(hydroxy)phosphoryl)oxy]phosphonic acid | C9H15N3O10P2 387.177 |  |
| YMDB00746 | dUDP 4208-67-7 | [({[(2R,3S,5R)-5-(2,4-dioxo-1,2,3,4-tetrahydropyrimidin-1-yl)-3-hydroxyoxolan-2-yl]methoxy}(hydroxy)phosphoryl)oxy]phosphonic acid | C9H14N2O11P2 388.1618 |  |
| YMDB16193 | Acetyl adenylate | (acetyloxy)({[(2R,3S,4R,5R)-5-(6-amino-9H-purin-9-yl)-3,4-dihydroxyoxolan-2-yl]methoxy})phosphinic acid | C12H16N5O8P 389.2579 |  |
| YMDB00402 | Phosphoribosyl pyrophosphate 7540-64-9 | [({[(2R,3R,4S,5R)-3,4-dihydroxy-5-[(phosphonooxy)methyl]oxolan-2-yl]oxy}(hydroxy)phosphoryl)oxy]phosphonic acid | C5H13O14P3 390.0696 |  |
| YMDB16249 | 1-phosphatidyl-1D-myo-inositol 4-phosphate | (2-{[2-(formyloxy)acetyl]oxy}ethoxy)[(2,3,4,5,6-pentahydroxycyclohexyl)oxy]phosphinic acid | C11H19O13P 390.2345 |  |
| YMDB00230 | 1-Phosphatidyl-D-myo-inositol | [2,3-bis(formyloxy)propoxy]({[(2R,3S,6S)-2,3,4,5,6-pentahydroxycyclohexyl]oxy})phosphinic acid | C11H19O13P 390.2345 |  |
| YMDB13280 | LPA(15:1(9Z)/0:0) | {2-hydroxy-3-[(9Z)-pentadec-9-enoyloxy]propoxy}phosphonic acid | C18H35O7P 394.445 |  |
| YMDB13281 | LPA(15:1(11Z)/0:0) | {2-hydroxy-3-[(11Z)-pentadec-11-enoyloxy]propoxy}phosphonic acid | C18H35O7P 394.445 |  |
| YMDB13300 | LPA(0:0/15:1(9Z)) | {3-hydroxy-2-[(9Z)-pentadec-9-enoyloxy]propoxy}phosphonic acid | C18H35O7P 394.445 |  |
| YMDB13301 | LPA(0:0/15:1(11Z)) | {3-hydroxy-2-[(11Z)-pentadec-11-enoyloxy]propoxy}phosphonic acid | C18H35O7P 394.445 |  |
| YMDB02320 | Dehydroergosterol 516-85-8 | (2S,5S,11R,14R,15R)-14-[(2R,3E,5R)-5,6-dimethylhept-3-en-2-yl]-2,15-dimethyltetracyclo[8.7.0.0²,⁷.0¹¹,¹⁵]heptadeca-1(17),7,9-trien-5-ol | C28H42O 394.6325 |  |
| YMDB00606 | ergosta-5,7,22,24(28)-tetraen-3beta-ol | (1S,2R,5S,11R,14R,15R)-2,15-dimethyl-14-[(2R,3E)-6-methyl-5-methylidenehept-3-en-2-yl]tetracyclo[8.7.0.0²,⁷.0¹¹,¹⁵]heptadeca-7,9-dien-5-ol | C28H42O 394.6325 |  |
| YMDB01535 | 9,12-Hexadecadienylcarnitine | (4S)-4-(hexadeca-9,12-dienoyloxy)-4-(trimethylazaniumyl)butanoate | C23H41NO4 395.5759 |  |
| YMDB13274 | LPA(15:0/0:0) | [2-hydroxy-3-(pentadecanoyloxy)propoxy]phosphonic acid | C18H37O7P 396.461 |  |